Heather Renfroe
Overview
Explore the profile of Heather Renfroe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz M, et al.
Transfusion
. 2011 Apr;
51(10):2175-82.
PMID: 21492180
Background: Plerixafor is a recently Food and Drug Administration (FDA)-approved CXCR4 antagonist, which is combined with granulocyte-colony-stimulating factor (G-CSF) to facilitate stem cell mobilization of lymphoma and myeloma patients. Study...
2.
Renfroe H, Arnold M, Vaughn L, Harvey R, Hamilton E, Lonial S, et al.
Transfusion
. 2011 Feb;
51(8):1779-83.
PMID: 21332729
Background: A study was undertaken to investigate whether granulocyte-colony-stimulating factor (G-CSF) injection in lower adipose tissue-containing sites (arms and legs) would result in a lower exposure and reduced stem cell...
3.
Lonial S, Kaufman J, Tighiouart M, Nooka A, Langston A, Heffner L, et al.
Clin Cancer Res
. 2010 Aug;
16(20):5079-86.
PMID: 20739431
Purpose: We did a randomized phase I/II trial designed to evaluate the safety and efficacy of combining the proteasome inhibitor bortezomib with high-dose melphalan as the conditioning for high-dose therapy...